Skip to main content

Table 2 Clinical, laboratory, and ART information of HIV infected children receiving ART in Amhara Region Referral Hospitals from January 1, 2012 to February 28, 2017

From: Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study

Variables Frequency (N) Percentage (%)
OI at baseline
 Yes 242 45.0
 No 296 55.0
Functional status (age 5 years) (N = 347)
 Working 195 56.2
 Ambulatory 144 41.5
 Bedridden 8 2.3
Developmental history (age < 5 years) (N = 191)   
 Appropriate 143 74.9
 Delayed 40 20.9
 Regressive 8 4.2
WHO clinical staging
 Stage I and II 310 57.6
 Stage III and IV 228 42.4
Past TB test before ART   
 Not determined 430 80.0
 Negative 53 9.9
 Positive 55 10.1
Past TB treatment
 No treatment 483 89.8
 2SRHZ/4RH 38 7.1
 2HRZES/4HRE 4 0.8
 HRZE/4RH 13 2.4
CD4 count or percent
 Severe immunodeficiency 374 69.5
 Mild immunodeficiency 164 30.5
Hemoglobin level
 Anemic(< 10 g/dl) 66 12.3
 Non-anemic (≥10 g/dl) 472 87.7
ART eligibility criteria
 Immunologic/ CD4 134 24.9
 WHO clinical stage 67 12.5
 Both clinical and immunologic 216 40.2
 Test and treat approach 121 22.5
Cotrimoxazole preventive therapy
 Yes 340 63.2
 No 198 36.8
ART adherence in the 1st 3 months
 Good /fair 495 92.2
 Poor 42 7.8
Underweight (baseline)
 Normal 317 58.9
 Moderate (WAZ < - 2) 128 23.8
 Severe (WAZ < −3) 93 17.3
Stunting (baseline)
 Normal 336 62.5
 Moderate (HAZ < −2) 80 14.9
 Severe (HAZ < −3) 122 22.7
Wasting (baseline)
 Normal 365 67.8
 Moderate (WHZ or BAZ < −2) 83 15.4
 Severe (WHZ or BAZ < − 3) 90 16.7